Guide

Growth equity explained

Harbor Analytics was a profitable B2B data platform at $38 million annual recurring revenue (ARR), growing 32% year over year with 18% EBITDA margins. The founders could fund operations from cash flow but could not afford a $15 million European sales build-out without starving product investment. A growth equity fund invested $48 million for a 28% stake at 7.5x ARR — minority capital, no control change, one board seat. Four years later ARR reached $112 million; the fund sold its stake in a secondary transaction at 9.2x ARR, returning 3.1x MOIC and roughly 26% gross IRR. That pattern — profitable company, large minority check, growth fueled by sponsor playbook — is the core of growth equity.

Growth equity sits between venture capital (early, often unprofitable startups) and leveraged buyouts (majority control with heavy debt). Sponsors inside private equity families run dedicated growth funds or sleeves that target scaling businesses needing expansion capital, bolt-on M&A firepower, or balance-sheet strength before an IPO. This guide covers typical company profiles, deal structure and governance, value-creation levers, return math, the Harbor Analytics model, a technique decision table versus VC and LBO, common pitfalls, and a diligence checklist.

What growth equity is

Growth equity (also called growth capital or expansion capital) is private financing where an institutional investor buys a minority equity stake in a company that is usually profitable or near-profitable, with proven product-market fit and a clear path to scale. Unlike VC, the business model works today; unlike an LBO, the sponsor does not load the balance sheet with acquisition debt or take operating control.

Checks typically range from $25 million to $250 million (mid-market funds) up to $500 million+ for large-cap growth platforms. Investors expect revenue growth of roughly 20–50% annually, improving unit economics, and an exit within four to seven years via IPO, strategic sale, or sponsor-to-sponsor secondary. Valuation often references ARR multiples for software, EBITDA multiples for services and industrials, or revenue multiples where margins are still compressing toward scale.

Minority or structured majority — classic deals leave founders in control; some structures use preferred equity with protective provisions without a change-of-control vote.
Primary capital — proceeds usually fund growth (hiring, geography, product lines), not a founder liquidity event — though partial secondary for early employees is common.
Lower loss rate than VC — portfolios are more diversified across fewer binary outcomes; returns cluster around 2–4x rather than power-law 0x or 50x.
Limited leverage — debt may supplement equity for add-on acquisitions but rarely approaches LBO 4–6x EBITDA leverage.

Where growth equity sits on the capital spectrum

Venture capital (early stage)

VC backs pre-profit companies proving product-market fit. Returns depend on a few outliers; failure rates are high. Dilution is frequent across seed, Series A, and B rounds. Growth equity often enters at Series C or later, or as the first institutional round for bootstrapped companies that skipped VC.

Growth equity (expansion stage)

The company has repeatable sales, known customer acquisition cost (CAC), and retention metrics. Capital accelerates what already works — new regions, enterprise sales teams, platform modules. Governance is collaborative: board seat, monthly KPI reviews, introduction to customers and hires.

Buyouts and LBOs (control stage)

Sponsors buy majority or full ownership, often with leveraged loans funding 60–70% of enterprise value. Value creation emphasizes cost takeout, working-capital optimization, and debt paydown. Growth equity rarely uses that capital structure because high-growth companies cannot support leverage without starving investment.

Typical entry criteria and valuation

Growth funds screen for businesses that can absorb capital efficiently:

Revenue scale — often $15M–$150M ARR (software) or $30M–$300M revenue (other sectors).
Growth rate — sustained 25%+ top-line growth; deceleration below 15% may push the deal toward buyout math.
Unit economics — LTV/CAC > 3x, payback under 18 months for SaaS; gross margin profiles that support S&M investment.
Market position — category leader or clear #2 in a large addressable market; not a feature at risk of platform bundling.
Management depth — CFO and VP Sales in place or recruitable; founders open to board accountability.

Software valuations often quote ARR multiples (6x–12x depending on growth, net retention, and margin). Industrials and healthcare services may use EBITDA multiples of 12x–18x when growth and margins justify a premium to public comps. Growth investors stress-test valuation against public SaaS trading multiples and recent comparable transactions, not only DCF, because exit is usually a multiple-based sale.

Deal structure and governance

Growth equity term sheets blend VC and PE conventions:

Security type — preferred equity with liquidation preference (typically 1x non-participating), anti-dilution (weighted average), and protective provisions on debt, M&A, and charter changes.
Board composition — investor seat, independent director mutually agreed, founder majority often retained.
Information rights — monthly financials, ARR bridge, cohort retention, pipeline coverage; annual audit at scale.
Secondary component — 10–30% of proceeds may buy shares from founders or early angels for life diversification without a full exit.
Option pool refresh — pre-money or post-money pool expansion for key hires; negotiated to limit founder dilution.

Covenants are lighter than LBO credit agreements: no maintenance leverage tests, but investors may cap additional debt without consent. Drag-along and tag-along rights align all shareholders on a sale. Registration rights matter when an IPO is the likely exit.

Value creation playbook

Growth sponsors earn returns primarily through revenue and EBITDA expansion, not financial engineering:

Go-to-market scaling — fund enterprise sales pods, channel partnerships, and marketing programs with measured CAC payback.
Geographic expansion — EU or APAC entities, localization, regulatory compliance (common in fintech and healthtech).
Product investment — adjacent modules that raise net revenue retention above 110% for SaaS platforms.
Strategic M&A — bolt-on acquisitions using equity plus modest debt; integration playbooks from prior portfolio companies.
Talent upgrade — recruit public-company-ready CFO, CRO, and general counsel ahead of IPO readiness.
Operational benchmarking — portfolio ops teams share pricing, packaging, and customer-success metrics across holdings.

Because sponsors lack control, alignment depends on trust and KPI contracts: annual budgets approved by the board, milestone-based tranches in some deals, and clear escalation paths if growth stalls.

Return math: how sponsors make money

Growth equity MOIC is driven by earnings growth and multiple change, with minimal deleveraging contribution:

Equity value at exit ≈ ARR_exit × multiple_exit × sponsor ownership %

Example sketch: invest $50M for 25% at $200M post-money (8x on $25M ARR). ARR grows to $90M in five years; exit at 9x ARR implies $810M EV; 25% stake worth $202M — roughly 4.0x MOIC before dilution from later rounds. If a Series D dilutes ownership to 20%, proceeds fall to $162M (3.2x). IRR depends on timing of follow-on reserves and any interim secondaries.

Funds model IRR against LP hurdles (often 8% preferred return before carry). Gross IRR bands of 20–30% are targeted; net to LPs is lower after management fees and carried interest. Unlike LBOs, there is no debt paydown lever — missing the growth plan hurts returns linearly rather than triggering covenant default.

Harbor Analytics: expansion model walkthrough

Harbor Growth Partners (composite name) led a 2022 round in Harbor Analytics, a vertical SaaS analytics vendor:

Entry: $38M ARR, 32% growth, 18% EBITDA margin; $48M primary + $8M founder secondary; 7.5x ARR pre-money; 28% ownership post-close.
Use of proceeds: DACH and UK sales offices ($12M), product localization ($6M), two tuck-in acquisitions ($18M), balance-sheet cushion ($12M).
Operating results: net revenue retention rose from 108% to 121%; ARR reached $112M by year four; EBITDA margin expanded to 24%.
Exit: strategic minority buyer paid 9.2x ARR ($1.03B EV); sponsor stake valued at ~$149M after dilution from employee options — 3.1x MOIC, ~26% gross IRR over 4.2 years.

Attribution: revenue growth contributed ~2.0x MOIC, multiple expansion from 7.5x to 9.2x ~0.8x, partial offset from dilution (~−0.7x). The deal would have returned ~1.9x if exit multiple matched entry — illustrating that growth equity lives or dies on execution, not leverage.

Technique decision table

Approach	Strength	Weakness	Best when
Growth equity	Funds proven models; founder-friendly control; no heavy debt	Needs scalable growth; minority governance limits; valuation sensitive	Profitable or near-profitable companies scaling faster than cash allows
Venture capital	Backs innovation early; tolerates long J-curves; network effects	High failure rate; dilutive multi-round paths; profit optional for years	Pre-revenue or early traction with large TAM upside
Leveraged buyout	Control and operational transformation; debt amplifies equity returns	Leverage risk; integration burden; illiquid majority stakes	Mature cash flows; actionable cost and pricing levers
Strategic corporate investment	Distribution synergies; customer validation	Competing priorities; acquisition optionality may cap valuation	Buyer seeks product partnership or tuck-in path
IPO / public markets	Liquidity and currency for M&A; broad investor base	Quarterly pressure; disclosure costs; market-window risk	Scale, governance, and metrics ready for public reporting

Common pitfalls

Paying VC multiples for decelerating growth — 12x ARR only works if net retention and growth reaccelerate; 20% growth at 12x is a expensive bet.
Ignoring follow-on reserve needs — pro-rata rights in later rounds require 50–100% of initial check in reserves or ownership dilutes sharply.
Founder secondary too large — if >40% of proceeds are seller liquidity, alignment on aggressive growth may weaken.
Under-diligenced cohort economics — headline ARR masks churn in legacy SKUs; stress-test cohort gross margin, not blended averages.
Geographic expansion without PMF proof — copying US playbooks into EU without local product-market validation burns capital.
Bolt-on M&A without integration capacity — two acquisitions in 18 months can stall core growth if PMO bandwidth is thin.
Board conflict without control — minority investors cannot fire founders; disputes require negotiated exits or drag rights that may not exist.
Exit timing versus public comps — SaaS multiple compression from 12x to 7x ARR wipes years of revenue growth from MOIC.

Production checklist

Validate ARR composition: recurring vs services, multi-year vs monthly contracts.
Build cohort retention and expansion revenue bridges for 24+ months.
Benchmark entry multiple against public comps and recent private transactions.
Model ownership through expected follow-on rounds with pro-rata assumptions.
Define use-of-proceeds budget with KPI gates for sales hiring and M&A.
Negotiate board seat, information rights, and protective provisions explicitly.
Cap founder secondary as a percentage of total round size.
Stress-test exit at flat, +1x, and −2x ARR multiple scenarios.
Align management equity refresh and vesting with four- to six-year exit horizon.
Document reserved capital for follow-ons in fund allocation models.
Plan IPO readiness milestones if public exit is base case.
Compare expected net IRR to LP hurdle after fees and carry.

Key takeaways

Growth equity provides minority expansion capital to profitable, scaling companies.
It bridges venture capital (early, high risk) and LBOs (control, leverage).
Returns come from revenue growth and multiple change, not debt paydown.
Harbor Analytics tripled ARR in four years; its growth sponsor returned 3.1x MOIC at 9.2x exit ARR.
Term sheets blend VC preferred equity with PE-style governance and reporting.
Entry multiple discipline and follow-on reserves matter as much as the operating plan.